Table 5.
Clinical characteristics and surgical indicators in pTNM III patients between laparoscopic total gastrectomy after neoadjuvant chemotherapy and laparoscopic total gastrectomy group
|
Variable
|
NC-LTG group (n = 34)
|
LTG group (n = 33)
|
P
value
|
| Sex | 0.324 | ||
| Male | 29 | 25 | |
| Female | 5 | 8 | |
| Age (yr, mean ± SD) | 59.56 ± 9.84 | 58.18 ± 12.85 | 0.623 |
| BMI (kg/m2, mean ± SD) | 23.24 ± 2.85 | 24.09 ± 3.20 | 0.250 |
| ASA grade | 0.160 | ||
| I | 3 | 1 | |
| II | 30 | 29 | |
| III | 1 | 3 | |
| Surgical time, min (mean ± SD) | 237.44 ± 46.86 | 228.03 ± 39.39 | 0.378 |
| Blood loss, mL (median, IQR) | 200 (100-500) | 100 (100-200) | 0.078 |
| Retrieved lymph nodes, n (mean ± SD) | 32.09 ± 12.32 | 31.58 ± 11.04 | 0.858 |
| Fist flatus day, d [median, (IQR)] | 4.0 (3.0-5.0) | 4.0 (3.0-5.0) | 0.844 |
| R0 resection rate, n (%) | 1 (2.9) | 3 (9.1) | 0.288 |
| Postoperative day, d [median, (IQR)] | 9.5 (7.0-11.0) | 8.0 (7.0-9.5) | 0.321 |
| Total complication rate, n (%) | 6 (17.6) | 6 (18.2) | 0.954 |
| Severe complication rate, n (%) | 2 (5.9) | 3 (9.1) | 0.617 |
NC-LTG: Laparoscopic total gastrectomy after neoadjuvant chemotherapy; LTG: Laparoscopic total gastrectomy; BMI: Body mass index; ASA: American Society of Anesthesiologists; IQR: Interquartile range.